Opportunity Information: Apply for PA 19 073

The NIH funding opportunity titled "Telomeres in Wellness and Disease: A Biobehavioral Approach (R21 Clinical Trial Optional)" (PA-19-073) is a discretionary grant program designed to spark early-stage, exploratory clinical research on how telomeres relate to both health and illness. The central aim is to move telomere science beyond basic associations and into biobehavioral research programs that can better explain, predict, and potentially improve real-world health outcomes. In practical terms, the FOA is looking for projects that connect telomere biology with behavioral, psychological, and social factors, and that test how these relationships may influence disease risk, symptom burden, recovery, and long-term wellness.

This opportunity is grounded in the growing evidence that telomeres, the protective DNA-protein structures at the ends of chromosomes, are linked to a range of health-related outcomes. Telomere length and related telomere-maintenance processes have been associated in prior work with aging, chronic disease risk, stress exposure, and other factors that sit at the intersection of biology and lived experience. Even with that foundation, NIH is signaling that the field still needs more targeted and methodologically strong clinical studies to fully harness telomere measures in ways that can guide prevention, support wellness, reduce disease burden, or improve symptom and self-management strategies. The emphasis on a "biobehavioral approach" highlights interest in research that does not treat telomeres as purely molecular endpoints, but instead integrates them into broader models that include behavior change, stress processes, health behaviors, social determinants, and clinical outcomes.

The activity mechanism is an R21, which typically supports exploratory, high-impact, and potentially higher-risk projects that can generate compelling preliminary data or open new research directions. The FOA is listed as "Clinical Trial Optional," meaning applicants may propose studies that either include or do not include a clinical trial component, depending on what best fits the research questions. The focus, however, remains on clinical research, so projects are generally expected to involve human participants and outcomes relevant to health, functioning, symptoms, or disease processes, rather than purely laboratory or animal work.

Funding details provided in the source indicate an award ceiling of $200,000. The opportunity is administered by the National Institutes of Health (NIH) and is tied to CFDA number 93.361, placing it within NIH's health research assistance portfolio. The original closing date listed is January 7, 2022, and the FOA was created on November 20, 2018, which matters for applicants because it suggests the listing is time-bounded and may now be expired or superseded by a reissued announcement. Even when an opportunity is no longer accepting applications, the description remains useful as a guide to NIH priorities and the kinds of projects that may fit similar, current FOAs.

Eligibility is broad and includes many types of organizations across government, education, nonprofit, and private sectors. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other Native American tribal organizations; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding higher education institutions when specified); for-profit organizations (other than small businesses) as well as small businesses; and additional entities classified as "other." The FOA also explicitly calls out additional eligible groups such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). That breadth suggests NIH is encouraging diverse institutional participation and potentially research in varied populations and settings, which fits well with the biobehavioral framing and the need to understand telomere-related processes across different life contexts.

Overall, the opportunity is aimed at building a stronger bridge between telomere biology and actionable clinical and behavioral science. It supports projects that can clarify when and how telomeres matter for health, and how telomere-informed approaches might eventually contribute to maintaining wellness, lowering disease risk, and improving symptom management and self-care in patient and community settings.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Telomeres in Wellness and Disease: A Biobehavioral Approach (R21 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.361.
  • This funding opportunity was created on 2018-11-20.
  • Applicants must submit their applications by 2022-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $200,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PA 19 073

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

FAQs: Telomeres in Wellness and Disease: A Biobehavioral Approach (R21 Clinical Trial Optional) (PA-19-073)

What is the goal of this NIH funding opportunity?

The goal is to support early-stage, exploratory clinical research that connects telomere biology to real-world health and illness through a biobehavioral lens. The emphasis is on moving beyond simple associations (for example, telomere length correlated with stress) toward studies that can better explain, predict, and potentially improve outcomes related to disease risk, symptom burden, recovery, and long-term wellness.

What does "biobehavioral approach" mean in this FOA?

"Biobehavioral" means the project should integrate telomere biology with behavioral, psychological, and social factors rather than treating telomeres as purely molecular endpoints. The FOA highlights interest in research models that include behavior change, stress processes, health behaviors, social determinants, and clinically relevant outcomes.

What types of research questions fit this opportunity?

Projects are expected to examine how telomere length and/or telomere-maintenance processes relate to wellness and disease in ways that are clinically meaningful. Examples of the kinds of directions implied include studying how behavioral and psychosocial factors interact with telomere biology to influence disease risk, symptoms, recovery trajectories, or self-management and wellness outcomes.

Is this opportunity focused on basic science or clinical research?

The focus is clinical research. While telomere biology is central, the FOA stresses studies involving human participants and outcomes relevant to health, functioning, symptoms, or disease processes, rather than purely laboratory or animal work.

Are clinical trials required?

No. The FOA is labeled "Clinical Trial Optional," meaning an application may include a clinical trial component or may propose a non-trial clinical study, depending on what best fits the research questions.

What is the activity mechanism, and what does it imply about project scope?

The activity mechanism is an R21, which typically supports exploratory, potentially higher-risk studies intended to generate preliminary data and open new research directions. This mechanism is commonly used for early-stage work that can spark follow-on research programs.

How much funding is available under this FOA?

The funding details provided indicate an award ceiling of $200,000.

Which agency is offering this grant opportunity?

The opportunity is administered by the National Institutes of Health (NIH).

What is the CFDA number associated with this opportunity?

The opportunity is tied to CFDA 93.361.

When was the FOA created, and what is the listed closing date?

The FOA was created on November 20, 2018, and the original closing date listed is January 7, 2022.

Is this FOA likely still open for applications?

Based on the listed closing date of January 7, 2022, it may be expired or superseded by a reissued announcement. The description can still be useful for understanding NIH priorities and for shaping projects for similar, current FOAs.

Who is eligible to apply?

Eligibility is broad and includes a wide range of organizations across government, education, nonprofit, and private sectors. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other Native American tribal organizations; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding higher education institutions when specified); for-profit organizations (other than small businesses) as well as small businesses; and additional entities classified as "other."

Does NIH encourage applications from specific institution types or communities?

Yes. The FOA explicitly calls out additional eligible groups such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and faith-based or community-based organizations.

Can federal agencies apply?

Yes. The FOA lists eligible federal agencies among the eligible applicant categories.

Are organizations in U.S. territories or possessions eligible?

Yes. The FOA includes U.S. territories or possessions among eligible applicants.

Are non-U.S. (foreign) organizations eligible?

Yes. The eligibility language includes non-U.S. entities (foreign organizations).

What kinds of outcomes does NIH seem to care about in this FOA?

The FOA emphasizes outcomes tied to prevention and wellness, lowering disease risk, reducing disease burden, improving symptom management, supporting self-care and self-management strategies, and understanding recovery and longer-term health trajectories in patient and community settings.

What is the scientific rationale for focusing on telomeres in this FOA?

The opportunity is grounded in evidence that telomeres (protective DNA-protein structures at chromosome ends) and related maintenance processes have been associated with aging, chronic disease risk, stress exposure, and other factors at the intersection of biology and lived experience. NIH indicates that the field still needs more targeted, methodologically strong clinical studies to better use telomere measures in actionable ways.

Is the FOA limited to studying telomere length only?

No. The description references telomere length and related telomere-maintenance processes, suggesting interest in more than length alone, as long as the work connects telomere biology to biobehavioral and clinically relevant questions.

Does the FOA support research across different populations and settings?

The broad eligibility and explicit inclusion of diverse institution types and community-based organizations suggests NIH is open to research in varied populations and settings. This aligns with the biobehavioral framing and the need to understand telomere-related processes across different life contexts.

If this FOA is closed, is the description still useful?

Yes. Even if the FOA is no longer accepting applications, the description can help teams understand NIH priorities and design projects that may fit similar, current NIH opportunities focused on telomere science, clinical research, and biobehavioral models.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Summer Seminars and Institutes for Higher Education Faculty

Previous opportunity: Telomeres in Wellness and Disease: A Biobehavioral Approach (R01 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 19 073

 

Applicants also applied for:

Applicants who have applied for this opportunity (PA 19 073) also looked into and applied for these:

Funding Opportunity
Independent Scientist Award (Parent K02 - Independent Basic Experimental Studies with Humans Required) Apply for PA 19 085

Funding Number: PA 19 085
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional) Apply for PAR 19 093

Funding Number: PAR 19 093
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 - Clinical Trial Optional) Apply for RFA DA 19 019

Funding Number: RFA DA 19 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R41/R42 - Clinical Trial Optional) Apply for RFA DA 19 020

Funding Number: RFA DA 19 020
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Clinical Research Centers (UG1 Clinical Trial Optional) Apply for RFA DA 19 025

Funding Number: RFA DA 19 025
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,500,000
HEAL Initiative Limited Competition: Behavioral Research to Improve MAT: Ancillary Studies to Enhance Behavioral or Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R01, Clinical Trials Optional) Apply for RFA AT 19 007

Funding Number: RFA AT 19 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000
HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (U01 Clinical Trial Optional) Apply for RFA HL 19 029

Funding Number: RFA HL 19 029
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $750,000
HEAL Initiative: Effectiveness Trials to Optimize, Implement, Scale, and Sustain the Collaborative Care Model for Individuals with Opioid Use Disorders and Mental Health Conditions (U01 Clinical Trial Required) Apply for RFA MH 19 525

Funding Number: RFA MH 19 525
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (R01 - Clinical Trial Not Allowed) Apply for RFA HL 19 028

Funding Number: RFA HL 19 028
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional) Apply for PAR 19 101

Funding Number: PAR 19 101
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $499,999
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) Apply for PAR 19 113

Funding Number: PAR 19 113
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) Apply for PA 19 111

Funding Number: PA 19 111
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) Apply for PA 19 112

Funding Number: PA 19 112
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed) Apply for PA 19 130

Funding Number: PA 19 130
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use Disorders (UG1 Clinical Trial Required) Apply for RFA DA 19 018

Funding Number: RFA DA 19 018
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required) Apply for PAR 19 133

Funding Number: PAR 19 133
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) Apply for PAR 19 136

Funding Number: PAR 19 136
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42 - Clinical Trial Not Allowed) Apply for RFA DA 19 030

Funding Number: RFA DA 19 030
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R43/R44 - Clinical Trial Not Allowed) Apply for RFA DA 19 031

Funding Number: RFA DA 19 031
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) Apply for RFA CA 19 028

Funding Number: RFA CA 19 028
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 19 073", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: